BioCentury
ARTICLE | Financial News

argenx raises $231M in follow-on

December 15, 2017 4:38 PM UTC

Antibody company argenx S.E. (Euronext:ARGX; NASDAQ:ARGX) raised $231 million through the sale of 4.4 million ADSs at $52 in a bumped-up follow-on underwritten by Cowen, Piper Jaffray, JMP Securities and Wedbush PacGrow. The price is a 5% discount to argenx’s NASDAQ close of $54.47 on Dec. 11, when it proposed after market close to raise $150 million. Each ADS represents one ordinary share...

BCIQ Company Profiles

argenx S.E.